Medline Lock-Up Expires Today — Insiders Can Sell: Watch for 5-15% Drop

This is not speculation — this is mechanics. When a lock-up expires, the supply of freely tradeable shares jumps. Insider selling isn't guaranteed, but it's likely, especially in a stock that's already down 30% from IPO highs and facing margin compression concerns. Here's what traders need to know before the bell.

The lock-up timeline: why today matters

• December 17, 2025: Medline IPOs at $29/share. PE sponsors (Blackstone, Carlyle, H&F, ADIA) locked up 180 days. These insiders own 52% of company.
• March-May 2026: PE sponsors execute staged 75M + 72M share secondaries. Pattern of insider desire to reduce stakes materializes early.
• Today, June 15, 2026: 180-day lock-up formally expires. Insiders now free to sell without SEC disclosure windows or staged offering restrictions.
• Expected outcome: 5–15% drop as supply floods market. Insiders unable to exit at $50 now race to sell at $35 on any bounce.

What's at stake for Medline stock today and this week

Most likely: MDLN -5–10% next few days as insiders sell. Once PE sponsors exit 30–40% of stakes (2–3 weeks), selling pressure eases. Stock stabilizes. Creates buying opportunity at $32–$35 for long-term holders. Quality business unchanged; supply dynamics changed.

Lock-up expirations are mechanical supply events, most destructive when fundamentals weak. MDLN has both working against it. Insiders already signaled desire to reduce stakes through March/May secondaries. Now they're free to accelerate. History suggests they will.

The lock-up mechanics: why today matters

• For regulators: Protects IPO from day-one insider cash-out that leaves public buyers with losses.
• For markets: Lockup spans ≥1 earnings report, forcing material info public before insider exits.
• For PE sponsors: Blackstone, Carlyle, H&F have been trapped for 6 months. Today: restriction ends. Exit strategy executes.

Lock-up expiration mechanics: what to expect

• Day 1 (today): Stock opens down 1–3% on anticipation. Insider testing. Volume spikes.
• Days 2–5: If weakness persists, insiders accelerate selling. Typical drop 5–10% cumulative by day 3.
• Weeks 2–4: Stragglers reduce stakes. Tail risk of -15% drop to $30 (near IPO price). Support typically holds at -15% from expiration price.

The trading setup: how to play MDLN

• Short MDLN: June 15–30 lock-up window. Short 1–2% portfolio. Target $32–$30. Cover on reversal or if stock closes >$37. Stop: $40.
• Long call spreads: Buy $35 calls, sell $25 calls. Breakeven $30. Max gain if stock holds $25–$30.
• Avoid long calls/stock now: Risk-reward terrible into lock-up expiration. Wait for capitulation to $28–$30.
• Watch volume: If close on >100M shares (2x normal), insiders testing market. More selling ahead validates short thesis.

How to trade MDLN from today forward

• If you own MDLN: (1) Hold and accept downside, (2) Sell and buy back cheaper, or (3) Sell 50% keep 50%.
• If you're long: Set stop-loss at $35. Break below = more downside likely.
• If you want to short: 3–5 day opportunity. Target $32–$34, cover there. Avoid shorting <$30 (risk/reward flips).
• Watch volume: 10–20M shares = insider dump confirmation. Light volume = measured approach.
• Key dates: June 15 (today, expires), June 19 (Iran deal signing), June 30 (Q2 earnings season).

The bottom line

Medline's lock-up expires TODAY. Not a surprise — scheduled 6 months. PE sponsors waiting to exit. Expect 5–15% downside over 1–2 weeks as insider selling peaks. This is mechanical, not fundamental. Quality unchanged. Supply dynamics changed. Traders anticipating sell-off profit. Panic sellers lose. Prepare now for next 3–5 days volatility. Set stops, define exit, decide: holder or trader?

IPO lock-up expirations, secondary offerings, insider transaction alerts, and corporate event calendars — delivered weekly so you're never caught off-guard by mechanical selldowns.

Frequently asked questions

Why does Medline's stock drop when the lock-up expires?
Insiders prevented from selling 180 days. When restriction lifts, can sell. Millions of shares suddenly available = higher supply. Same demand + higher supply = lower price. Quality unchanged, supply dynamics changed. Mechanical, not fundamental.

How much could MDLN drop?
Historically 60% of IPOs decline 5–15% at lock-up expiry. MDLN already down $50.88 highs to $37. Expect another 5–10% ($32–$35) next 1–2 weeks as PE sponsors exit. Tail risk: capitulation to $26–$29 if panic.

Should I sell my Medline stock today?
Three options: (1) Sell and buy back cheaper $32–$35 (optimal but emotionally hard), (2) Hold and accept temporary 5–10% downside (passive), (3) Sell 50% keep 50% (balanced). Choose based on risk tolerance.

What's the buying opportunity for MDLN?
Once PE sponsors mostly exit (2–3 weeks), selling pressure eases. Stock stabilizes $31–$35. Long-term buyers accumulate here. Quality business unchanged; lock-up expiration is temporary supply pressure, not deterioration.

How long will insider selling pressure last?
Peak 1–2 weeks post-expiration as insiders rush to exit. By week 3–4, PE sponsors sold 30–50% stakes and market stabilizes. Full exits take months, but most aggressive selling happens first 2–3 weeks.